Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03874650
Other study ID # 2026112018
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 20, 2019
Est. completion date April 27, 2021

Study information

Verified date May 2021
Source University of Cambridge
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Low mood and depression are common following acquired brain injury (ABI). There is a lack evidence on effective treatments in ABI. Behavioural Activation (BA) is a potentially valuable option. People with low mood can have problems imagining, planning and engaging in positive activities, or avoid activities due to fear of negative consequences. This can reduce positive reinforcement, further lowering mood. BA aims to reverse this cycle by encouraging individuals to engage in enjoyable activities. Despite its simplicity, it has been as effective as "talking therapies" and mood medication in non-ABI populations. Its simplicity may be particularly helpful in ABI where cognitive problems can form additional barriers to activity engagement. This study will examine two ways to increase activity levels and improve mood. The first (Activity Engagement Group) is a social group run once a week for 8 weeks in which ABI participants will be encouraged to engage in games, crafts and discussion. The aim is that members gain direct positive reinforcement and may challenge fears such that activity levels could be maintained and mood enhanced after the group ends. The second approach (Activity Planning Group), again an 8-week group, is to help participants identify, plan and schedule positive activities. The group will include discussion on identifying and overcoming problems in planning activities. Again, the hope is that training skills in planning and scheduling will generalise beyond the group. The primary purpose is to examine the practicality, feasibility, and acceptability of the two approaches in ABI. A secondary purpose is to evaluate whether either group leads to improvements in activity levels and mood compared to a waitlist group. Individuals will be randomised to the Activity Engagement, Activity Planning Group or the 8-week Waitlist group. All will complete measures of activity levels and mood. At the end of the groups, these measures will be repeated. Waitlist participants will then be re-randomised to either the Activity Engagement Group or the Activity Planning Group. Recruitment rates, drop out rates, and exit interviews will be used to assess feasibility and how meaningful or valuable participants found the groups. Comparison of measures will provide some indication of whether the groups are associated with improvements compared to those waitlisted. To establish whether any benefits last, all participants will repeat the measures 1 month after the groups end.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date April 27, 2021
Est. primary completion date April 27, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Have a diagnosis of an acquired brain injury (e.g., traumatic brain injury, stroke) 2. Speak and comprehend English 3. Are a minimum of 3 months post-acquired brain injury 4. Are identified as having low mood. Low mood will be identified by either: 1. A score of at least 7 on the depression subscale of the Hospital Anxiety and Depression Scale, indicating clinically significant levels of depression, or 2. Clinicians have identified that a client has low mood (i.e., through their own administration of the HADS within the past 3 months, through clinical interview determining that the client has low mood or would benefit emotionally from increased activity level) Exclusion Criteria: 1. Are incapable of attending to and/or understanding the intervention materials (i.e., severe cognitive disability) 2. Have a diagnosis of dementia or other neurodegenerative disorder 3. Unstable psychotropic medication (i.e., have recently started/recently changed medications) 4. Are actively suicidal (i.e., have attempted suicide in the past 3 months, currently self-harm, and/or have a concrete plan to attempt suicide in the future, as identified by recurring clinician)

Study Design


Intervention

Behavioral:
Activity Planning Group
Participants in this group will receive 8 1-hour sessions of Behavioural Activation combined with select Goal Management Training strategies over the course of 8 weeks.
Activity Engagement Group
Participants in this group will attend 8 1-hour sessions of various social activities such as board games and puzzles.
Waitlist Group
Participants in this group will continue on their care as usual before being re-randomised into either the Activity Planning Group or Activity Engagement Group after 8 weeks.

Locations

Country Name City State
United Kingdom Cambridge University Hospitals NHS Trust Cambridge
United Kingdom Cambridgeshire Community Services Cambridge Cambs

Sponsors (1)

Lead Sponsor Collaborator
University of Cambridge

Country where clinical trial is conducted

United Kingdom, 

References & Publications (25)

Brown M, Dijkers MP, Gordon WA, Ashman T, Charatz H, Cheng Z. Participation objective, participation subjective: a measure of participation combining outsider and insider perspectives. J Head Trauma Rehabil. 2004 Nov-Dec;19(6):459-81. — View Citation

Carleton RN, Norton MA, Asmundson GJ. Fearing the unknown: a short version of the Intolerance of Uncertainty Scale. J Anxiety Disord. 2007;21(1):105-17. Epub 2006 May 2. — View Citation

Carver CS, White TL. Behavioural inhibition, behavioural activation, and affective responses to impending reward and punishment: The BIS/BAS scales. J Pers Soc Psychol, 67, 319-333, 1994.

Cattelani R, Zettin M, Zoccolotti P. Rehabilitation treatments for adults with behavioral and psychosocial disorders following acquired brain injury: a systematic review. Neuropsychol Rev. 2010 Mar;20(1):52-85. doi: 10.1007/s11065-009-9125-y. Epub 2010 Feb 9. Review. Erratum in: Neuropsychol Rev. 2011 Jun;21(2):224. — View Citation

Dimidjian S, Hollon SD, Dobson KS, Schmaling KB, Kohlenberg RJ, Addis ME, Gallop R, McGlinchey JB, Markley DK, Gollan JK, Atkins DC, Dunner DL, Jacobson NS. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol. 2006 Aug;74(4):658-70. — View Citation

Fazel S, Wolf A, Pillas D, Lichtenstein P, Långström N. Suicide, fatal injuries, and other causes of premature mortality in patients with traumatic brain injury: a 41-year Swedish population study. JAMA Psychiatry. 2014 Mar;71(3):326-33. doi: 10.1001/jamapsychiatry.2013.3935. — View Citation

Hyder AA, Wunderlich CA, Puvanachandra P, Gururaj G, Kobusingye OC. The impact of traumatic brain injuries: a global perspective. NeuroRehabilitation. 2007;22(5):341-53. Review. — View Citation

Jorge RE, Robinson RG, Moser D, Tateno A, Crespo-Facorro B, Arndt S. Major depression following traumatic brain injury. Arch Gen Psychiatry. 2004 Jan;61(1):42-50. — View Citation

Kanter JW, Manos RC, Bowe WM, Baruch DE, Busch AM, Rusch LC. What is behavioral activation? A review of the empirical literature. Clin Psychol Rev. 2010 Aug;30(6):608-20. Review. — View Citation

Kanter JW, Mulick PS, Busch AM, et al. The Behavioural Activation for Depression Scale (BADS): Psychometric properties and factor structure. J Psychopathol Behav 29(3), 191-202, 2007.

Lachman ME, Weaver SL. Sociodemographic variations in the sense of control by domain: findings from the MacArthur studies of midlife. Psychol Aging. 1998 Dec;13(4):553-62. — View Citation

Lachman ME, Weaver SL. The sense of control as a moderator of social class differences in health and well-being. J Pers Soc Psychol. 1998 Mar;74(3):763-73. — View Citation

Levine B, Robertson IH, Clare L, Carter G, Hong J, Wilson BA, Duncan J, Stuss DT. Rehabilitation of executive functioning: an experimental-clinical validation of goal management training. J Int Neuropsychol Soc. 2000 Mar;6(3):299-312. — View Citation

Levine B, Schweizer TA, O'Connor C, Turner G, Gillingham S, Stuss DT, Manly T, Robertson IH. Rehabilitation of executive functioning in patients with frontal lobe brain damage with goal management training. Front Hum Neurosci. 2011 Feb 17;5:9. doi: 10.3389/fnhum.2011.00009. eCollection 2011. — View Citation

Mazzucchelli T, Kane R, Rees CS. Behavioural activation treatments for depression in adults: A meta-analysis and review. Clin Psychol-Sci Pr 16(4): 383-411, 2009.

McDonald S, Tate R, Togher L, Bornhofen C, Long E, Gertler P, Bowen R. Social skills treatment for people with severe, chronic acquired brain injuries: a multicenter trial. Arch Phys Med Rehabil. 2008 Sep;89(9):1648-59. doi: 10.1016/j.apmr.2008.02.029. — View Citation

Medley AR, Powell T. Motivational Interviewing to promote self-awareness and engagement in rehabilitation following acquired brain injury: A conceptual review. Neuropsychol Rehabil. 2010 Aug;20(4):481-508. doi: 10.1080/09602010903529610. Epub 2010 Feb 1. Review. — View Citation

Oddy M, Cattran C, Wood R. The development of a measure of motivational changes following acquired brain injury. J Clin Exp Neuropsychol. 2008 Jul;30(5):568-75. doi: 10.1080/13803390701555598. — View Citation

Richards DA, Ekers D, McMillan D, Taylor RS, Byford S, Warren FC, Barrett B, Farrand PA, Gilbody S, Kuyken W, O'Mahen H, Watkins ER, Wright KA, Hollon SD, Reed N, Rhodes S, Fletcher E, Finning K. Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trial. Lancet. 2016 Aug 27;388(10047):871-80. doi: 10.1016/S0140-6736(16)31140-0. Epub 2016 Jul 23. — View Citation

Roozenbeek B, Maas AI, Menon DK. Changing patterns in the epidemiology of traumatic brain injury. Nat Rev Neurol. 2013 Apr;9(4):231-6. doi: 10.1038/nrneurol.2013.22. Epub 2013 Feb 26. Review. — View Citation

Teasell R, Bayona N, Marshall S, Cullen N, Bayley M, Chundamala J, Villamere J, Mackie D, Rees L, Hartridge C, Lippert C, Hilditch M, Welch-West P, Weiser M, Ferri C, McCabe P, McCormick A, Aubut JA, Comper P, Salter K, Van Reekum R, Collins D, Foley N, Nowak J, Jutai J, Speechley M, Hellings C, Tu L. A systematic review of the rehabilitation of moderate to severe acquired brain injuries. Brain Inj. 2007 Feb;21(2):107-12. Review. — View Citation

Turner-Stokes L. Evidence for the effectiveness of multi-disciplinary rehabilitation following acquired brain injury: a synthesis of two systematic approaches. J Rehabil Med. 2008 Oct;40(9):691-701. doi: 10.2340/16501977-0265. — View Citation

Waldron B, Casserly LM, O'Sullivan C. Cognitive behavioural therapy for depression and anxiety in adults with acquired brain injury: what works for whom? Neuropsychol Rehabil. 2013;23(1):64-101. doi: 10.1080/09602011.2012.724196. Epub 2012 Nov 5. Review. — View Citation

Whelan-Goodinson R, Ponsford J, Johnston L, Grant F. Psychiatric disorders following traumatic brain injury: their nature and frequency. J Head Trauma Rehabil. 2009 Sep-Oct;24(5):324-32. doi: 10.1097/HTR.0b013e3181a712aa. — View Citation

Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-70. — View Citation

* Note: There are 25 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Behavioural Activation for Depression Scale (BADS; Kanter et al., 2007) This measure assesses changes in activity level related to depression. It consists of four subscales, Activation (engaging in meaningful activities) and Avoidance/Rumination (avoiding meaningful activities), Work/School impairment, and Social Impairment. To score the BADS, items from all scales other than the Activation scale are reverse-coded and then all items are summed. To score the subscales, no items are reverse-coded. For the total scale, higher scores represent increased activation, while for the Social Impairment subscale, higher scores represent increased social impairment. The minimum possible score on the BADS is 0, while the maximum possible is 150. Baseline, 1 week post-intervention, 1 month post-intervention
Secondary Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983) This measure assesses levels of depression (subscale 1) and anxiety (subscale 2) in clinical settings. Each subscale is scored independently. On each subscale, each item is summed with no reverse-coded items. Greater scores on either subscale represent greater depression or anxiety. The minimum possible score on each subscale is 0, while the maximum possible score on each subscale is 21. Higher scores indicate greater depression and anxiety. Baseline, 1 week post-intervention, 1 month post-intervention
Secondary Behavioural Inhibition/Behavioural Activation Scales (BIS/BAS; Carver & White 1994) This measures assesses individual disposition toward avoiding and engaging in activities. The BIS/BAS has three behavioural activation (BA) subscales, and only one subscale assesses behavioural inhibition (BI). The BA subscales are Drive, Fun Seeking, and Reward Responsiveness. All items except for two are reverse coded. Four items are filler questions and are not used for the subscale scores. Once the appropriate questions are reverse coded, each subscale is summed to get the respective subscale scores. The minimum score on BA Drive is 4, maximum 16. Higher scores indicate greater drive to engage. The minimum score on the BA Fun Seeking subscale is 4, maximum 16. Higher scores indicate greater fun seeking. The minimum score on the BA Reward Responsiveness subscale is 5, maximum 20. Higher scores indicate greater reward responsiveness.The minimum score on the BI subscale is 7, maximum 28. Greater scores indicate greater behavioural inhibition. Baseline, 1 week post-intervention, 1 month post-intervention
Secondary Intolerance of Uncertainty Scale-Short Form (IUS-SF; Carleton, Norton, & Asmundson) This measure assesses the degree to which an individual is bothered by uncertainty. The IUS-SF has two subscales, Prospective Anxiety (concerns about the future), and Inhibitory (concerns prevent one from doing things). The items on the subscale are summed. No items are reverse-coded. A total score can be produced from combining two subscales. The minimum score on the Prospective Anxiety subscale is 5, maximum 25. Greater scores indicate greater prospective anxiety. The minimum score on the Inhibitory Anxiety subscale is 7, maximum 35. Greater scores indicate greater inhibitory anxiety. Baseline, 1 week post-intervention, 1 month post-intervention
Secondary Impact of Events Scale-Revised (IES-R, Weiss, 2007) This measure assesses acute and routine life stress. The IES-R has three subscales, Avoidance (not thinking of stressful events), Intrusion (whether memories of stressful events occur) and Hyperarousal (The degree to which stressful events cause somatic symptoms). No items are reverse-coded. Although each subscale can produce a score, typically the total score is summed to determine the level of impact a stressful event has had on an individual. The items on the subscale are summed, ranging from 0 to 88. Scores 24 or higher indicate cause for clinical concern, 33 represents a probably diagnosis of post-traumatic stress disorder, and 37 is high enough to suppress immune function (i.e., severe clinical concern). Baseline, 1 week post-intervention, 1 month post-intervention
Secondary Brain Injury Rehabilitation Trust Motivation Questionnaire-Self (BMQ-S) This measure assesses difficulties with overall motivation after brain injury. The scale has no subscales, and has 15 reverse-scored items. Once the appropriate questions are reverse scored, all items are summed to generate a total score. The minimum possible score is 34, maximum 136. Greater scores indicate greater difficulties with motivation. Baseline, 1 week post-intervention, 1 month post-intervention
Secondary Modified Outcome Measure - Participation Objective, Participation Subjective (MOM-POPS, Brown et al., 2004) This is a modified measure of desired and actual participation in home and community activities. The scale contains 3 items, asking participants to rate their involvement in, frequency of, and importance of household, occupational, and social activities. Participants are then asked to check off which activities they have engaged in the past week, such as cleaning the house, made social arrangements, attended religious services, etc. Each item is scored individually, hence there is no score total. The first 3 items represent desired participation in daily activities, and the final item represents actual participation. Baseline, 1 week post-intervention, 1 month post-intervention
Secondary Sense of Control Scale (SCS; Lachman & Weaver, 1998a, 1998b) This measure assesses perceived ability to exert control over one's life. It consists of two subscales, Perceived Constraints (i.e., whether there are barriers to control) and Perceived Mastery (one's subjective belief about their competency in one's life). All items on the perceived constraints scale are reverse coded. Each subscale is summed and interpreted independently. The minimum possible score on the Perceived Constraints scale is 8, maximum 56. Greater scores indicate more constraints.The minimum possible score on the Perceived Mastery subscale is 4, maximum 28. Greater scores indicate greater mastery. Baseline, 1 week post-intervention, 1 month post-intervention
Secondary Motivation for Traumatic Brain Injury Rehabilitation Questionnaire (MOT-Q; Chervinsky et al., 1998) This scale assesses level of motivation toward rehabilitation-related activities in traumatic brain injury. It consists of 4 subscales, Lack of Denial (good insight), Interest in Rehabilitation, Lack of Anger, and Reliance on Professional Help. The MOT-Q uses a 5-point Likert scale from -2 to +2. The scale contains 19 reverse coded items. Each subscale is totaled separately, and can be added together to produce a total score. Higher scores indicate greater motivation for rehabilitation. Total scores can range from -62 to +62. The Lack of Denial subscale ranges from -16 to +16, with higher scores indicating better insight. The Interest in Rehabilitation subscale ranges from -14 to +14, with greater scores indicating greater interest. The Lack of Anger scubscale ranges from -20 to +20, with higher scores indicating lower anger. The Reliance on Professional Help subscale ranges from -12 to +12, with higher scores indicating greater reliance. Baseline, 1 week post-intervention, 1 month post-intervention
Secondary Credibility/Expectancy Questionnaire (CEQ; Devilly & Borkovec, 2000) This scale assesses participant expectations of treatment outcome and perceived credibility of treatment. It consists of 6 items. The first 4 items reflect what one think about the intervention, and the last 2 items evaluate how one feels about the intervention. This measure has two factors, Credibility and Expectancy. The Credibility subscale ranges from 3 to 27. Two items on the Expectancy subscale are perecentage based (0 to 100%) and the third item is Likert based from 1 to 9. Typically, items are evaluated individually rather than produce a scale total Baseline only
Secondary Snaith Hamilton Pleasure Scale (SHAPS; Snaith et al., 1995) This scale assesses level of ability to experience pleasure in day-to-day activities. It consists on 14 items, with 7 items reverse coded. Greater scores indicate greater ability to experience pleasure in daily activities. Once the appropriate items are reverse-coded, all items are summed. The minimum possible score is 14, maximum 56. Baseline, 1 week post-intervention, 1 month post-intervention
Secondary Fatigue Severity Scale (FSS; Krupp et al., 1989) This scale assess overall levels of fatigues in patient populations within the past week. It consists of 7 Likert-rated items and one visual analogue scale for participants to rate overall fatigue. Greater scores indicate higher levels of fatigue. The minimum possible score is 7, maximum 49. Baseline, 1 week post-intervention, 1 month post-intervention
Secondary Generalized Anxiety Disorder-7 (GAD-7; Spitzer et al., 2006) This scale measures symptoms of generalized anxiety disorder such as excessive worry and irritability, over the past two weeks. It consists of 8 items, with greater scores indicating greater anxiety. The minimum possible score is 0, and the highest possible score is 24. Baseline, 1 week post-intervention, 1 month post-intervention
Secondary Patient Health Questionnaire-9 (PHQ-9; Kroenke et al., 2001) This scale measures symptoms of depression such as poor appetite or difficulties concentrating, over the past two weeks. It consists of 8 items, with greater scores indicating greater anxiety. The minimum possible score is 0, and the highest possible score is 24. Baseline, 1 week post-intervention, 1 month post-intervention
Secondary Verbal and Spatial Reasoning Test (VESPAR; Langdon & Warrington, 1995) This neuropsychological assessment measures fluid intelligence in neurological patients. It consists of 3 verbal and 3 spatial reasoning tasks, designed to calculate an individual's IQ. Baseline only
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT04977232 - Adjunctive Game Intervention for Anhedonia in MDD Patients N/A
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Completed NCT04476446 - An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives Phase 3
Recruiting NCT02783430 - Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease Phase 2/Phase 3
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT04598165 - Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Completed NCT05588622 - Meru Health Program for Cancer Patients With Depression and Anxiety N/A
Recruiting NCT05234476 - Behavioral Activation Plus Savoring for University Students N/A
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Enrolling by invitation NCT03276585 - Night in Japan Home Sleep Monitoring Study
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A